JPS6159637B2 - - Google Patents

Info

Publication number
JPS6159637B2
JPS6159637B2 JP54146642A JP14664279A JPS6159637B2 JP S6159637 B2 JPS6159637 B2 JP S6159637B2 JP 54146642 A JP54146642 A JP 54146642A JP 14664279 A JP14664279 A JP 14664279A JP S6159637 B2 JPS6159637 B2 JP S6159637B2
Authority
JP
Japan
Prior art keywords
reaction
group
chloroform
acid
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP54146642A
Other languages
Japanese (ja)
Other versions
JPS5671099A (en
Inventor
Hideo Sakakibara
Tatsuro Fujiwara
Susumu Watanabe
Tetsuo Matsuda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyo Jozo KK
Original Assignee
Toyo Jozo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyo Jozo KK filed Critical Toyo Jozo KK
Priority to JP14664279A priority Critical patent/JPS5671099A/en
Priority to NL8004922A priority patent/NL8004922A/en
Priority to DE19803033032 priority patent/DE3033032A1/en
Priority to US06/184,375 priority patent/US4345069A/en
Priority to GB8029019A priority patent/GB2058765B/en
Priority to FR8019987A priority patent/FR2465747A1/en
Priority to CA000360427A priority patent/CA1192542A/en
Priority to CH699780A priority patent/CH645650A5/en
Priority to IT24738/80A priority patent/IT1141057B/en
Priority to ES495214A priority patent/ES495214A0/en
Publication of JPS5671099A publication Critical patent/JPS5671099A/en
Priority to ES503606A priority patent/ES503606A0/en
Publication of JPS6159637B2 publication Critical patent/JPS6159637B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明は、抗生物質タイロシンの新規誘導体に
関する。さらに詳しくは、本発明は、20−デオキ
ソデスマイコシン(20−デオキソ−4′−デマイカ
ロシルタイロシン)またはその塩である。 本発明の化合物は、新規化合物であつて、式 で表わされる。 上記の塩としては、医薬上許容できる塩であ
る。このような適当な塩としては、塩酸、硫酸、
リン酸などの無機酸との塩、酢酸、プロピオン
酸、酒石酸、クエン酸、コハク酸、リンゴ酸、ア
スパラギン酸、グルタミン酸などの有機酸との塩
が包含される。その他の非毒性塩も包含される。 上記の新規化合物〔〕は、原料であるタイロ
シンよりグラム陽性菌に対して極めて強い抗菌活
性を有することは、第1表より明らかであり、臨
床上優れた感染治療効果の期待される物質であ
る。また動物用治療薬剤、飼料添加剤としても有
用である。
The present invention relates to new derivatives of the antibiotic tylosin. More specifically, the present invention is 20-deoxodesmycosine (20-deoxo-4'-demycarosyltylosin) or a salt thereof. The compound of the present invention is a novel compound and has the formula It is expressed as The above salts are pharmaceutically acceptable salts. Such suitable salts include hydrochloric acid, sulfuric acid,
Included are salts with inorganic acids such as phosphoric acid, and salts with organic acids such as acetic acid, propionic acid, tartaric acid, citric acid, succinic acid, malic acid, aspartic acid, and glutamic acid. Other non-toxic salts are also included. It is clear from Table 1 that the above new compound [] has extremely stronger antibacterial activity against Gram-positive bacteria than the raw material tylosin, and is a substance that is expected to have clinically excellent infection treatment effects. . It is also useful as a therapeutic drug for animals and a feed additive.

【表】 上記目的化合物〔〕は、タイロシンの19位
CHO基をCH2OH基に還元し、このCH2OH基を
CH3基に変換し、得られた20−デオキソタイロシ
ンを稀酸で脱4′−マイカロシル化することにより
得られる。 19位CHO基のCH2OH基への還元は、9位の
CO基を還元しないような温和な条件で還元する
ような公知の還元方法により行なわれる。好適な
方法としては、NaBH4を用いる方法が挙げら
れ、好ましくは、Antimicrobial Agents and
Chemotherapy 1963,45(1964)に記載の方法
に準じて行なうのがよい。例えば7.5附近のPHを
有する含水メタノール中室温でNaBH4を反応さ
せればよい。反応時間はシリカゲルなどの薄層ク
ロマトグラフイーにより追跡できるので、タイロ
シンの消失を待つて適宜反応を終了すればよい。
得られた生成物は反応液を非親水性有機溶媒、例
えばクロロホルムで抽出することにより採取さ
れ、特に精製することなく次の反応に用いること
ができる。 19位CH2OH基をCH3基に変換するには、種々
の公知の方法によつて行なうことができる。例え
ばCH2OH基のOH基をトシル化し、次いでNaI+
Znでp−トルエンスルホン酸エステルを還元的
に脱離する方法によつて行なうことができる。 上記のトシル化は第3級有機アミン、例えばピ
リジンなどの脱酸剤および溶媒としての存在下p
−トルエンスルホニルハライドを反応させること
により行なわれる。反応の経過はシリカゲルなど
の薄層クロマトグラフイーにより追跡できるの
で、前記生成物、即ち20−ジヒドロ体の消失を待
つて適宜反応を終了すればよい。反応後を水中に
あけ、PH8〜10に調節して適当な非親水性有機溶
媒、例えばクロロホルムで抽出することにより20
位OH基がトシル化された生成物を採取すること
ができる。この生成物は、特に精製することな
く、次の反応に用いることができる。次に、この
p−トルエンスルホン酸エステルを還元的に脱離
するのであるが、この反応は適当な有機溶媒、例
えばエチレングリコールジメチルエーテル中で
NaIとZnの存在下加熱することにより行なわれ
る。上記の反応は、先ずCH2O−トシル基がCH2I
基に変換し、これがZnにより還元されてCH3に変
換するものである。反応の経過はシリカゲルなど
の薄層クロマトグラフイーにより追跡できるの
で、20位OH基がトシル化された生成物の消失を
待つて適宜反応を終了すればよい。このようにし
て得られた20−デオキソタイロシンを反応液から
採取するには、Znを別した反応液を水中にあ
け、非親水性有機溶液、例えばクロロホルムで抽
出することにより行なわれる。 次に、この20−デオキソタイロシンを脱4′−マ
イカロシル化するのであるが、この反応は稀酸、
例えば0.5N程度の塩酸で加水分解すればよい。
加水分解の時間は、シリカゲルなどの薄層クロマ
トグラフイーにより追跡できるので、20−デオキ
ソタイロシンの消失を待つて適宜反応を終了すれ
ばよい。 また、上記目的化合物〔〕は、次の別法によ
つても製造することができる。即ち、上記の製造
工程において、19位CHO基をCH2OH基に還元す
る前に、脱4′−マイカロシル化する方法である。
この場合の各工程における反応は、前記反応工程
と同様な条件で行なえばよい。 このようにして得られた20−デオキソデスマイ
コシンを反応液から採取するには、反応液をアン
モニア水などのアルカリで中和し、適当な非親水
性有機溶媒、例えばクロロホルムで抽出すること
により行なわれる。さらに精製を必要とする場合
には、シリカゲル、活性アルミナ、吸着樹脂など
の吸着剤を用いるカラムクロマトグラフイーによ
り精製することができる。 次に、実施例を挙げて本発明の製造例を具体的
に説明する。 尚、実施例中のRf値は、特記しない限り次の
担体および展開溶媒を用いる薄層クロマトグラフ
イー(TLC)により測定したものである。 担体;メルク社製シリカゲル60プレート
Art5721 展開溶媒;クロロホルムーメタノール−酢酸 水(80:7:7:1) 実施例 1 20−デオキソデスマイコシン タイロシン5gを0.2Mリン酸緩衝液(PH7.5)
−メタノール(1:1)の混液150mlに溶かし、
これにNaBH4150mgを上記混液10mlに溶かした溶
液を加え、室温で1.5時間撹拌した後希アンモニ
ア水でPH9.5とし、反応液をクロロホルム100mlで
抽出する。クロロホルム層を水洗し、無水硫酸マ
グネシウムで乾燥後、減圧乾固して粗製の20−ジ
ヒドロタイロシン(UVλEtoH nax283nm、Rf=0.1
5)
を得る。 上記生成物をピリジン20mlに溶かし、これに塩
化トシル1.25gを加え、室温で16時間撹拌する。
反応液に濃アンモニア水5mlを加え、15分間撹拌
した後、水500ml中にあけ、クロロホルム100mlで
抽出する。クロロホルム層を水、希塩酸、水、希
アンモニア水の順に洗浄し、無水硫酸マグネシウ
ムで乾燥後、減圧乾固する。得られた粉末3.3g
をエチレングリコールジメチルエーテル30mlに溶
かし、これにヨウ化ナトリウム2.3g、亜鉛粉末
2gを加え、3時間加熱還流する。反応混合物を
過して亜鉛粉末を除去し、液に水100mlを加
え、希アンモニア水でPH9.5としクロロホルム100
mlで抽出する。クロロホルム層を水洗し、無水硫
酸マグネシウムで乾燥後、減圧乾固して粗製の20
−デオキソタイロシン(Rf=0.24)を得る。 上記生成物を0.5N塩酸50mlに溶かし、室温で
18時間撹拌する。反応液をアンモニア水でPH9.5
とし、クロロホルム100mlで抽出する。クロロホ
ルム層を水洗し、無水硫酸マグネシウムで乾燥
後、減圧乾固して20−デオキソデスマイコシンの
粗粉末2.2gを得る。この粉末をクロロホルム−
メタノール(15:1)を用いるシリカゲルカラム
クロマトグラフイーにより精製し、精製品780mg
を得る。 TLC;Rf=0.32 UVλEtoH nax283nm(ε=19700)Mass(m/
e);757(M+)、739,612,567,394,393,
377,359,358,190,174,173 NMR(100MHz、CDCl3);1.79(12−CH3)、
2.51(3′−N(CH32)、3.42および3.49
(OCH3)ppm、アルデヒド消失
[Table] The above target compound [] is at position 19 of tylosin.
CHO group is reduced to CH 2 OH group, and this CH 2 OH group is
It can be obtained by converting it into a CH 3 group and de-4'-mycarosylating the obtained 20-deoxotylosine with a dilute acid. The reduction of the 19-position CHO group to the CH 2 OH group is performed by reducing the 9-position CHO group to the
The reduction is carried out using a known reduction method that performs reduction under mild conditions that do not reduce the CO group. Suitable methods include methods using NaBH4 , preferably Antimicrobial Agents and
Chemotherapy 1963, 45 (1964). For example, NaBH 4 may be reacted at room temperature in aqueous methanol having a pH of around 7.5. Since the reaction time can be monitored by thin layer chromatography using silica gel or the like, the reaction can be appropriately terminated after waiting for the disappearance of tylosin.
The obtained product is collected by extracting the reaction solution with a non-hydrophilic organic solvent, such as chloroform, and can be used in the next reaction without particular purification. The CH 2 OH group at position 19 can be converted to a CH 3 group by various known methods. For example, the OH group of CH 2 OH group is tosylated and then NaI+
This can be carried out by a method in which p-toluenesulfonic acid ester is reductively eliminated using Zn. The above tosylation is carried out in the presence of a tertiary organic amine, e.g. pyridine, as a deoxidizing agent and as a solvent.
- by reacting toluenesulfonyl halide. Since the progress of the reaction can be monitored by thin layer chromatography using silica gel or the like, the reaction can be appropriately terminated after waiting for the disappearance of the product, ie, the 20-dihydro compound. After the reaction, the mixture is poured into water, the pH is adjusted to 8 to 10, and the mixture is extracted with a suitable non-hydrophilic organic solvent such as chloroform.
A product in which the OH group is tosylated can be collected. This product can be used in the next reaction without particular purification. Next, this p-toluenesulfonic acid ester is removed reductively, and this reaction is carried out in a suitable organic solvent, such as ethylene glycol dimethyl ether.
This is done by heating in the presence of NaI and Zn. In the above reaction, the CH 2 O-tosyl group is first converted into CH 2 I
This is reduced by Zn and converted to CH 3 . Since the progress of the reaction can be monitored by thin layer chromatography using silica gel or the like, the reaction can be appropriately terminated after waiting for the disappearance of the product in which the OH group at the 20-position is tosylated. In order to collect the 20-deoxotylosine thus obtained from the reaction solution, the reaction solution from which Zn has been removed is poured into water and extracted with a non-hydrophilic organic solution, such as chloroform. Next, this 20-deoxotylosine is de-4'-mycarosylated, and this reaction is carried out using a dilute acid,
For example, it may be hydrolyzed with about 0.5N hydrochloric acid.
Since the hydrolysis time can be tracked by thin layer chromatography using silica gel or the like, the reaction can be appropriately terminated after waiting for the disappearance of 20-deoxotylosine. Moreover, the above-mentioned target compound [] can also be produced by the following alternative method. That is, in the above production process, the 19-position CHO group is de-4'-mycarosylated before being reduced to a CH 2 OH group.
The reaction in each step in this case may be carried out under the same conditions as in the reaction step. In order to collect the 20-deoxodesmycosine thus obtained from the reaction solution, the reaction solution is neutralized with an alkali such as aqueous ammonia and extracted with an appropriate non-hydrophilic organic solvent such as chloroform. This is done by If further purification is required, it can be purified by column chromatography using an adsorbent such as silica gel, activated alumina, or adsorption resin. Next, production examples of the present invention will be specifically explained with reference to Examples. The Rf values in the examples were measured by thin layer chromatography (TLC) using the following carrier and developing solvent, unless otherwise specified. Carrier: Merck silica gel 60 plate
Art5721 Developing solvent: Chloroform-methanol-acetic acid water (80:7:7:1) Example 1 20-deoxodesmycocin 5 g of tylosin in 0.2M phosphate buffer (PH7.5)
-Dissolved in 150 ml of methanol (1:1) mixture,
A solution of 150 mg of NaBH 4 dissolved in 10 ml of the above mixture was added to this, and after stirring at room temperature for 1.5 hours, the pH was adjusted to 9.5 with dilute ammonia water, and the reaction solution was extracted with 100 ml of chloroform. The chloroform layer was washed with water, dried over anhydrous magnesium sulfate, and dried under reduced pressure to obtain crude 20-dihydrotylosin (UVλ EtoH nax 283 nm, Rf=0.1
Five)
get. The above product was dissolved in 20 ml of pyridine, 1.25 g of tosyl chloride was added thereto, and the mixture was stirred at room temperature for 16 hours.
Add 5 ml of concentrated ammonia water to the reaction solution, stir for 15 minutes, pour into 500 ml of water, and extract with 100 ml of chloroform. The chloroform layer is washed successively with water, dilute hydrochloric acid, water, and dilute ammonia water, dried over anhydrous magnesium sulfate, and then dried under reduced pressure. 3.3g of powder obtained
was dissolved in 30 ml of ethylene glycol dimethyl ether, 2.3 g of sodium iodide and 2 g of zinc powder were added thereto, and the mixture was heated under reflux for 3 hours. The reaction mixture was filtered to remove zinc powder, 100 ml of water was added to the solution, the pH was adjusted to 9.5 with dilute ammonia water, and 100 ml of chloroform was added.
Extract in ml. The chloroform layer was washed with water, dried over anhydrous magnesium sulfate, and dried under reduced pressure to obtain crude 20
-Deoxotylosin (Rf=0.24) is obtained. Dissolve the above product in 50ml of 0.5N hydrochloric acid and let it stand at room temperature.
Stir for 18 hours. The reaction solution was adjusted to PH9.5 with aqueous ammonia.
and extract with 100 ml of chloroform. The chloroform layer was washed with water, dried over anhydrous magnesium sulfate, and dried under reduced pressure to obtain 2.2 g of crude powder of 20-deoxodesmycocin. This powder was mixed with chloroform.
Purified by silica gel column chromatography using methanol (15:1) to obtain 780 mg of purified product.
get. TLC; Rf=0.32 UVλ EtoH nax 283nm (ε=19700) Mass (m/
e); 757 (M + ), 739, 612, 567, 394, 393,
377, 359, 358, 190, 174, 173 NMR (100MHz, CDCl3 ); 1.79 (12- CH3 ),
2.51 (3'-N( CH3 ) 2 ), 3.42 and 3.49
(OCH 3 )ppm, aldehyde disappearance

Claims (1)

【特許請求の範囲】[Claims] 1 20−デオキソデスマイコシンまたはその塩。1 20-deoxodesmycosin or its salt.
JP14664279A 1979-09-19 1979-11-13 20-deoxodesmycosin Granted JPS5671099A (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
JP14664279A JPS5671099A (en) 1979-11-13 1979-11-13 20-deoxodesmycosin
NL8004922A NL8004922A (en) 1979-09-19 1980-08-29 DEFORMYLTYLOSINE DERIVATIVES.
DE19803033032 DE3033032A1 (en) 1979-09-19 1980-09-02 DEFORMYLTYLOSIN DERIVATIVES
US06/184,375 US4345069A (en) 1979-09-19 1980-09-05 Deformyltylosin derivatives
GB8029019A GB2058765B (en) 1979-09-19 1980-09-09 Deformyltylosin derivatives
FR8019987A FR2465747A1 (en) 1979-09-19 1980-09-17 DEFORMYLTYLOSINE DERIVATIVES USEFUL AS ANTIBIOTICS
CA000360427A CA1192542A (en) 1979-09-19 1980-09-17 Deformyltylosin derivatives
CH699780A CH645650A5 (en) 1979-09-19 1980-09-18 DEFORMYLTYLOSIN DERIVATIVES.
IT24738/80A IT1141057B (en) 1979-09-19 1980-09-18 DEFORMYLTYLOSINE DERIVATIVES AND THEIR PREPARATION
ES495214A ES495214A0 (en) 1979-09-19 1980-09-19 PROCEDURE FOR OBTAINING NEW DEFOR-MILTYLOSINO DERIVATIVES
ES503606A ES503606A0 (en) 1979-09-19 1981-07-01 PRODUCTION PROCEDURE OF 20-DEOXO-4-SEMICARORILTILOMIAO OF A SALT OF THE SAME.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14664279A JPS5671099A (en) 1979-11-13 1979-11-13 20-deoxodesmycosin

Publications (2)

Publication Number Publication Date
JPS5671099A JPS5671099A (en) 1981-06-13
JPS6159637B2 true JPS6159637B2 (en) 1986-12-17

Family

ID=15412334

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14664279A Granted JPS5671099A (en) 1979-09-19 1979-11-13 20-deoxodesmycosin

Country Status (1)

Country Link
JP (1) JPS5671099A (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4443436A (en) * 1982-09-13 1984-04-17 Eli Lilly And Company C-20-Modified macrolide derivatives of the macrolide antibiotics tylosin, desmycosin, macrocin, and lactenocin
ZA841277B (en) * 1983-02-28 1985-09-25 Lilly Co Eli C-20-and c-23-modified macrolide derivatives

Also Published As

Publication number Publication date
JPS5671099A (en) 1981-06-13

Similar Documents

Publication Publication Date Title
JP2751385B2 (en) Process for producing erythromycin A oxime and its salt
JPS6360031B2 (en)
JP3771128B2 (en) Novel synthesis method of febrifugine and febrifugine compounds
JPS6159637B2 (en)
JPS6312063B2 (en)
EP0381989B1 (en) New 4'-epi-4'-amino anthracyclines
FR2749585A1 (en) NOVEL AROMATIC DERIVATIVES SUBSTITUTED BY RIBOSIS, PROCESS FOR THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS
EP0475071B1 (en) 2-acyloxy-4-morpholinyl anthracycline
JPS6319499B2 (en)
JP2000503666A (en) Camptothecin isolated from Mappia foetida-backbone compounds and their use as synthons for novel pharmaceutical and therapeutic agents
JPH0768163B2 (en) Process for producing cyclopentenone derivative
JP3285391B2 (en) Method for producing 2-phenoxybenzoic acid
JP3544727B2 (en) Method for preparing 2,4,5-tribromopyrrole-3-carbonitrile
JPS63307894A (en) Ring-reduced macrolide antibiotic
JPS59199693A (en) Indolylglycylcephalosporin derivative
JPH07103148B2 (en) Anthracycline-macrolide complex
DE69614030T2 (en) Production and use of 7 - ((2-carbo-alkoxy-1-methylethenyl) amino) -3-hydroxymethyl-3-cephem-4-carboxylic acids
JPS634826B2 (en)
JPH0510358B2 (en)
JPH02129199A (en) Enol ethers of elaiophyrin and manufacture thereof
JP2504934B2 (en) 1,6,7-Triacylforskolin derivative
JP2710052B2 (en) Code factor-related compound, method for producing the same, and immunopotentiator containing the compound
JPS6034985A (en) 23-acylamino-23-deoxydemycinosyl-desmycosin derivative and its preparation
JP2571939B2 (en) Cyclopentenone derivatives and their production
GB2201419A (en) Anthracycline-oestrone derivatives